Clinical Trials Logo

Clinical Trial Summary

Study to Evaluate the Mass Balance and Biotransformation of Single Dose [14C]-Larotinib(Z650)in healthy male subjects.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05059743
Study type Interventional
Source Sunshine Lake Pharma Co., Ltd.
Contact liyan Miao, MD
Phone 0512-67972858
Email [email protected]
Status Not yet recruiting
Phase Phase 1
Start date December 30, 2021
Completion date December 30, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04873063 - Evaluation of Systemic Bioavailability and Effects on 24-Hour Plasma Cortisol Profile of 6 mg Delivered Once Daily Versus 3 mg Delivered Twice Daily in Healthy Adult Male Volunteers Phase 1
Completed NCT04616742 - Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers Phase 1
Completed NCT04260373 - Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR4640 in Chinese Healthy Adult Male Volunteers. Phase 1